Non-invasive tracking of CD4 + T cells with a paramagnetic and fluorescent nanoparticle in brain ischemia

Journal of Cerebral Blood Flow and Metabolism

Volumn 36, Issue 8, 2016, Pages 1464-1476

  Jin, Wei Na ^a,b   Yang, Xiaoxia ^a   Li, Zhiguo ^b   Li, Minshu ^a,b   Shi, Samuel Xiang Yu ^b   Wood, Kristofer ^b   Liu, Qingwei ^b   Fu, Ying ^a   Han, Wei ^a   Xu, Yun ^c   Shi, Fu Dong ^a,b   Liu, Qiang ^a,b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b BARROW NEUROLOGICAL INSTITUTE   (United States)

^c MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

CD4 + T cells; In vivo imaging; Ischemic stroke; lymphocytes; USPIO

Indexed keywords

MOLDAY ION RHODAMINE B; NANOPARTICLE; RHODAMINE B; SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; FLUORESCENT DYE; MAGNETITE NANOPARTICLE; RAG2 PROTEIN, MOUSE; RHODAMINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN ISCHEMIA; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CELL ISOLATION; CELL LABELING; CELL SURVIVAL; CELL TRACKING; COMPARATIVE STUDY; CONTROLLED STUDY; FLOW CYTOMETRY; FLUORESCENCE IMAGING; FLUORESCENCE MICROSCOPY; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRE-CLINICAL IMAGING DEVICE; PRIORITY JOURNAL; SPLEEN CELL; TISSUE SECTION; ANIMAL; BLOOD; C57BL MOUSE; CHEMISTRY; CYTOLOGY; DIAGNOSTIC IMAGING; FLUORESCENCE; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; PROCEDURES; STAINING;

ANIMALS; BRAIN ISCHEMIA; CD4-POSITIVE T-LYMPHOCYTES; CELL TRACKING; DNA-BINDING PROTEINS; FLUORESCENCE; FLUORESCENT DYES; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT; RHODAMINES; STAINING AND LABELING;

EID: 84982946679     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1177/0271678X15611137     Document Type: Article

References (39)

1. Gelderblom M, Leypoldt F, Steinbach K, et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009; 40: 1849-1857.
2. Iadecola C and Anrather J. The immunology of stroke: From mechanisms to translation. Nat Med 2011; 17: 796-808.
3. Chamorro A, Meisel A, Planas AM, et al. The immunology of acute stroke. Nat Rev Neurol 2012; 8: 401-410.
4. Fu Y, Zhang N, Ren L, et al. Impact of an immune modulator fingolimod on acute ischemic stroke. Proc Natl Acad Sci U S A 2014; 111: 18315-18320.
5. Gan Y, Liu Q, Wu W, et al. Ischemic neurons recruit natural killer cells that accelerate brain infarction. Proc Natl Acad Sci U S A 2014; 111: 2704-2709.
6. Kamel H and Iadecola C. Brain-immune interactions and ischemic stroke: Clinical implications. Arch Neurol 2012; 69: 576-581.
7. Becker KJ. Activation of immune responses to brain antigens after stroke. J Neurochem 2012; 123: 148-155.
8. Liesz A, Suri-Payer E, Veltkamp C, et al. Regulatory t cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 2009; 15: 192-199.
9. Yilmaz G, Arumugam TV, Stokes KY, et al. Role of t lymphocytes and interferon-gamma in ischemic stroke. Circulation 2006; 113: 2105-2112.
10. Kleinschnitz C, Schwab N, Kraft P, et al. Early detrimental t-cell effects in experimental cerebral ischemia are neither related to adaptive immunity nor thrombus formation. Blood 2010; 115: 3835-3842.
11. Clarkson BD, Ling C, Shi Y, et al. T cell-derived interleukin (il)-21 promotes brain injury following stroke in mice. J Exp Med 2014; 211: 595-604.
12. Shichita T, Sugiyama Y, Ooboshi H, et al. Pivotal role of cerebral interleukin-17-producing gammadeltat cells in the delayed phase of ischemic brain injury. Nat Med 2009; 15: 946-950.
13. Ahrens ET and Bulte JW. Tracking immune cells in vivo using magnetic resonance imaging. Nat Rev Immunol 2013; 13: 755-763.
14. Anderson SA, Shukaliak-Quandt J, Jordan EK, et al. Magnetic resonance imaging of labeled t-cells in a mouse model of multiple sclerosis. Ann Neurol 2004; 55: 654-659.
15. Moore A, Sun PZ, Cory D, et al. Mri of insulitis in autoimmune diabetes. Magn Reson Med 2002; 47: 751-758.
16. Kircher MF, Allport JR, Graves EE, et al. In vivo high resolution three-dimensional imaging of antigen-specific cytotoxic t-lymphocyte trafficking to tumors. Cancer Res 2003; 63: 6838-6846.
17. Weinstein JS, Varallyay CG, Dosa E, et al. Superparamagnetic iron oxide nanoparticles: Diagnostic magnetic resonance imaging and potential therapeutic applications in neurooncology and central nervous system inflammatory pathologies, a review. J Cereb Blood Flow Metab 2010; 30: 15-35.
18. Oude Engberink RD, Blezer EL, Hoff EI, et al. Mri of monocyte infiltration in an animal model of neuroinflammation using spio-labeled monocytes or free uspio. J Cereb Blood Flow Metab 2008; 28: 841-851.
19. Shen WB, Plachez C, Chan A, et al. Human neural progenitor cells retain viability, phenotype, proliferation, and lineage differentiation when labeled with a novel iron oxide nanoparticle, molday ion rhodamine b. Int J Nanomed 2013; 8: 4593-4600.
20. Hao J, Liu R, Piao W, et al. Central nervous system (cns)-resident natural killer cells suppress th17 responses and cns autoimmune pathology. J Exp Med 2010; 207: 1907-1921.
21. Liu Q, Tang Z, Gan Y, et al. Genetic deficiency of beta2-containing nicotinic receptors attenuates brain injury in ischemic stroke. Neuroscience 2014; 256: 170-177.
22. Tang Z, Gan Y, Liu Q, et al. Cx3cr1 deficiency suppresses activation and neurotoxicity of microglia/macrophage in experimental ischemic stroke. J Neuroinflam 2014; 11: 26.
23. Bell JC, Liu Q, Gan Y, et al. Visualization of inflammation and demyelination in 2d2 transgenic mice with rodent mri. J Neuroimmunol 2013; 264: 35-40.
24. Daldrup-Link HE, Meier R, Rudelius M, et al. In vivo tracking of genetically engineered, anti-her2/neu directed natural killer cells to her2/neu positive mammary tumors with magnetic resonance imaging. Eur Radiol 2005; 15: 4-13.
25. Sheu AY, Zhang Z, Omary RA, et al. Mri-monitored transcatheter intra-arterial delivery of spio-labeled natural killer cells to hepatocellular carcinoma: Preclinical studies in a rodent model. Invest Radiol 2013; 48: 492-499.
26. Wang Q, Li K, Quan Q, et al. R2 and r2 mapping for quantifying recruitment of superparamagnetic iron oxidetagged endothelial progenitor cells to injured liver: Tracking in vitro and in vivo. Int J Nanomed 2014; 9: 1815-1822.
27. Shi FD and Van Kaer L. Reciprocal regulation between natural killer cells and autoreactive t cells. Nat Rev Immunol 2006; 6: 751-760.
28. Carmichael ST. Rodent models of focal stroke: Size, mechanism, and purpose. NeuroRx 2005; 2: 396-409.
29. Sta Maria NS, Barnes SR and Jacobs RE. In vivo monitoring of natural killer cell trafficking during tumor immunotherapy. Magn Reson Insight 2014; 7: 15-21.
30. Mori Y, Chen T, Fujisawa T, et al. From cartoon to real time mri: In vivo monitoring of phagocyte migration in mouse brain. Sci Rep 2014; 4: 6997.
31. Dekaban GA, Hamilton AM, Fink CA, et al. Tracking and evaluation of dendritic cell migration by cellular magnetic resonance imaging. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2013; 5: 469-483.
32. Bulte JW and Kraitchman DL. Iron oxide mr contrast agents for molecular and cellular imaging. NMR Biomed 2004; 17: 484-499.
33. Siglienti I, Bendszus M, Kleinschnitz C, et al. Cytokine profile of iron-laden macrophages: Implications for cellular magnetic resonance imaging. J Neuroimmunol 2006; 173: 166-173.
34. Ahrens ET, Feili-Hariri M, Xu H, et al. Receptormediated endocytosis of iron-oxide particles provides efficient labeling of dendritic cells for in vivo mr imaging. Magn Reson Med 2003; 49: 1006-1013.
35. He T, Wang Y, Xiang J, et al. In vivo tracking of novel spio-molday ion rhodamine-b-labeled human bone marrow-derived mesenchymal stem cells after lentivirusmediated cox-2 silencing: A preliminary study. Curr Gene Ther 2014; 14: 136-145.
36. Martin A, Aguirre J, Sarasa-Renedo A, et al. Imaging changes in lymphoid organs in vivo after brain ischemia with three-dimensional fluorescence molecular tomography in transgenic mice expressing green fluorescent protein in t lymphocytes. Mol Imag 2008; 7: 157-167.
37. Liesz A, Hagmann S, Zschoche C, et al. The spectrum of systemic immune alterations after murine focal ischemia: Immunodepression versus immunomodulation. Stroke 2009; 40: 2849-2858.
38. Prass K, Meisel C, Hoflich C, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke t helper cell type 1-like immunostimulation. J Exp Med 2003; 198: 725-736.
39. Chu HX, Kim HA, Lee S, et al. Immune cell infiltration in malignant middle cerebral artery infarction: Comparison with transient cerebral ischemia. J Cereb Blood Flow Metab 2014; 34: 450-459.